These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9987522)

  • 1. [Clinical studies conducted in the U.S].
    Mizuno K
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):217-24. PubMed ID: 9987522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New Japanese GCP--from the standpoint of a sponsor].
    Ebi O
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New recommendations for evaluating the effectiveness of treatment of solid tumors and principles of the Guidelines for Clinical Practice (GCP)].
    Gorbunova VA; Orel NF; Zaruk VA
    Vopr Onkol; 2001; 47(6):718-21. PubMed ID: 11826496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improving the infrastructure for clinical trials in Japan].
    Nakano S
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):225-30. PubMed ID: 9987523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy].
    Shimoyama M
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):235-46. PubMed ID: 9987525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of highly specialized clinical drug trial units within health care institutions].
    Stanimirović V; Babić M; Nikolić D; Cucak S; Nikolić A
    Srp Arh Celok Lek; 2000; 128(7-8):253-8. PubMed ID: 11089432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Good clinical practice in clinical trials: training clinicians,incentives to apply good clinical practice and assessment of compliance].
    Belorgey C; Demarez JP; Jaillon P;
    Therapie; 2002; 57(4):339-46. PubMed ID: 12422554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organization, administration, and performance of clinical studies].
    Bachner M; Steininger T; Gneist M
    Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigator and site selection and performing GCP clinical studies in India.
    Maggon K
    Control Clin Trials; 2004 Aug; 25(4):366-77. PubMed ID: 15296811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
    Akiyama T; Furuta M; Yamada H
    Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.